Impact of polypharmacy on 3-year mortality in patients with heart failure: a retrospective study

• Váldodahkkit: Daisuke Hayashi (Dahkki), Yoshiaki Kubota (Dahkki), Takuya Nishino (Dahkki), Yukihiro Watanabe (Dahkki), Yoshiki Iwade (Dahkki), Junya Matsuda (Dahkki), Katsuhito Kato (Dahkki), Shuhei Tara (Dahkki), Yuya Ise (Dahkki), Yu-ki Iwasaki (Dahkki), Kuniya Asai (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2024-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Guideline-directed medical therapy (GDMT) is important in heart failure management; however, polypharmacy itself may impact heart failure. Although measures against polypharmacy are needed, current discussion on unilateral drug tapering (including the drugs that should be tapered...